Sebastian Ursich
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Research Interests
Sebastian Ursich has a total of 6 co-authors. Here are the top co-authors by number of shared publications:
Camilla Trovesi
Dipartimento di Biotecnologie e Bioscienze, Università di Milano‐Bicocca, Milano, Italy
1 shared publicationLuca Menin
Dipartimento di Biotecnologie e Bioscienze, Università di Milano‐Bicocca, Milano, Italy
1 shared publication- Maria Pia Longhese
Dipartimento di Biotecnologie e Bioscienze, Università degli Studi di Milano-Bicocca, Milano, Italy
1 shared publication - Massimo Lopes
Institute of Molecular Cancer Research (IMCR), University of Zurich, Zurich, Switzerland
1 shared publication - Michela Clerici
Department of Biotechnology and Biosciences, University of Milano-Bicocca, 20126 Milan, Italy
1 shared publication Ralph Zellweger
Institute of Molecular Cancer Research, University of Zurich, Zurich, Switzerland
1 shared publication
Latest Publications
- 8 May 2018
- Published by Springer Nature in EMBO Reports
- Vol. 19 (7) , e201745535
Tel1/ATM prevents degradation of replication forks that reverse after topoisomerase poisoning
In both yeast and mammals, the topoisomerase poison camptothecin (CPT) induces fork reversal, which has been proposed to stabilize replication forks, thus providing time for the repair of CPT‐induced lesions and supporting replication restart. We show that Tel1, the Saccharomyces cerevisiae orthologue of human ATM kinase, stabilizes CPT‐induced reversed forks by counteracting their nucleolytic degradation by the MRX complex. Tel1‐lacking cells are hypersensitive to CPT specifically and show less reversed forks in the presence of CPT. The lack of Mre11 nuclease activity restores wild‐type levels of reversed forks in CPT‐treated tel1Δ cells without affecting fork reversal in wild‐type cells. Moreover, Mrc1 inactivation prevents fork reversal in wild‐type, tel1Δ, and mre11 nuclease‐deficient cells and relieves the hypersensitivity of tel1Δ cells to CPT. Altogether, our data indicate that Tel1 counteracts Mre11 nucleolytic activity at replication forks that undergo Mrc1‐mediated reversal in the presence of CPT. Synopsis The topoisomerase poison camptothecin (CPT) induces fork reversal, which is thought to stabilize replication forks. Here, yeast Tel1, orthologue of human ATM, protects CPT‐induced reversed forks from nucleolytic degradation by the MRX complex. The absence of Tel1 or its kinase activity causes a specific hypersensitivity to CPT and decreases fork reversal in CPT. The decreased reversed fork levels in the absence of Tel1 are due to unscheduled nucleolytic processing that depends mainly on Mre11 nuclease activity. Tel1 function in reversed fork stabilization becomes dispensable when fork reversal is prevented by the lack of the replisome‐associated factor Mrc1, whose absence also relieves the hypersensitivity to CPT of tel1Δ cells.
- 8 May 2018
- Published by Springer Nature in EMBO Reports
- Vol. 19 (7) , e201745535
Tel1/ATM prevents degradation of replication forks that reverse after topoisomerase poisoning
In both yeast and mammals, the topoisomerase poison camptothecin (CPT) induces fork reversal, which has been proposed to stabilize replication forks, thus providing time for the repair of CPT‐induced lesions and supporting replication restart. We show that Tel1, the Saccharomyces cerevisiae orthologue of human ATM kinase, stabilizes CPT‐induced reversed forks by counteracting their nucleolytic degradation by the MRX complex. Tel1‐lacking cells are hypersensitive to CPT specifically and show less reversed forks in the presence of CPT. The lack of Mre11 nuclease activity restores wild‐type levels of reversed forks in CPT‐treated tel1Δ cells without affecting fork reversal in wild‐type cells. Moreover, Mrc1 inactivation prevents fork reversal in wild‐type, tel1Δ, and mre11 nuclease‐deficient cells and relieves the hypersensitivity of tel1Δ cells to CPT. Altogether, our data indicate that Tel1 counteracts Mre11 nucleolytic activity at replication forks that undergo Mrc1‐mediated reversal in the presence of CPT. Synopsis The topoisomerase poison camptothecin (CPT) induces fork reversal, which is thought to stabilize replication forks. Here, yeast Tel1, orthologue of human ATM, protects CPT‐induced reversed forks from nucleolytic degradation by the MRX complex. The absence of Tel1 or its kinase activity causes a specific hypersensitivity to CPT and decreases fork reversal in CPT. The decreased reversed fork levels in the absence of Tel1 are due to unscheduled nucleolytic processing that depends mainly on Mre11 nuclease activity. Tel1 function in reversed fork stabilization becomes dispensable when fork reversal is prevented by the lack of the replisome‐associated factor Mrc1, whose absence also relieves the hypersensitivity to CPT of tel1Δ cells.